Scientific Programme
 |
12:45 - 14:15 Oral Session 4 - Diagnosis and staging of urothelial tumours I
| Overview J. Carballido, Madrid (ES) |
| 26: Impact of diagnostic ureteroscopy on intravesical recurrence and survival in patients with upper urinary tract cancer S.I. Ishikawa, Sapporo (JP) |
| 27: Endoscopic manipulation of upper tract urothelial carcinoma results in a higher risk of subsequent bladder recurrence S. Taneja, New York (US) |
| 28: Optical coherence tomography and hexaminolevulinate fluorescence cystoscopy in detecting urothelial carcinoma of the bladder J. Schmidbauer, Vienna (AT) |
| 29: Voided urine cytology: An unnecessary expense in the haematuria pathway? J. Pati, London (GB) |
| 30: Multi-institutional evaluation of the predictive value of p53 immunohistochemical staining in patients with pT1-2 N0 disease at radical cystectomy S.F. Shariat, Dallas (US) |
| 31: Independent predictors of contra lateral metachronous upper urinary tract transitional cell carcinoma after nephroureterectomy: multi-institutional dataset from 3 European centres G. Novara, Padua (IT) |
| 32: Development and internal validation of a novel nomogram predicting bladder cancer specific survival of patients with pt0 disease following radical cystectomy. Results from a two institution series B.G. Volkmer, Kassel (DE) |
| 33: Prospective study Uroscreen- significance of urine-based tumour markers for screening high-risk populations for bladder cancer G. Feil, Tübingen (DE) |
| Summary P. Graziotti, Padua (IT) |